Results 211 to 220 of about 127,568 (322)

Hypertrophic Cardiomyopathy: Pathophysiology, Genetics and Invasive Treatment

, 2011
Michelle Michels
openalex   +1 more source

SAFETY AND OUTCOMES OF CONCOMITANT AFICAMTEN AND DISOPYRAMIDE USE AND WITHDRAWAL IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: AN ANALYSIS OF REDWOOD-HCM COHORT 3, SEQUOIA-HCM, AND FOREST-HCM TRIALS

Ahmad Masri, Theodore P. Abraham, Michael E. Nassif, Roberto Barriales‐Villa, Ozlem Bilen, Caroline Coats, Perry Elliott, Daniele Massera, Iacopo Olivotto, Artur Oręziak, Anjali Owens, Sara Saberi, Scott D. Solomon, Albree Tower‐Rader, Stephen B. Heitner, Jozef Bartúnek, Stuart Kupfer, Fady I. Malik, Chiara Melloni, Jenny Wei, Amy Wohltman, Martin S. Maron, Mark V. Sherrid   +22 more
openalex   +1 more source

Tissue‐Specific Extraction and Structural Elucidation of Actin‐Tropomyosin‐Myosin Complexes from Human and Rodent

Aggregate, Volume 7, Issue 1, January 2026.
We developed a general tissue‐extraction strategy that directly purifies native F‐actin and actin–tropomyosin–myosin (ATM) complexes from human and rodent muscles for cryo‐EM. Near‐atomic structures, including an HCM R404Q mouse model, reveal how a disease myosin mutation remodels ATM assembly and alters myosin conformation at the actin interface ...
Danni Li, Qinyue Zhao, Youqi Tao, Shiran Lv, Wanbing Zhao, Yunxia Li, Xingyu Xiong, Zhizhi Wang, Wenqing Xu, Yaoyang Zhang, Cong Liu, Weidong Le, Wenyan Kang, Dan Li, Qin Cao, Bin Dai   +15 more
wiley   +1 more source

Apical Hypertrophic Cardiomyopathy: A Rare and Hidden Cause of Stroke. [PDF]

Cureus
Stringer I, Patel A, Edhem L, Delamere R, Eni G, Ahmed A, Solano J.   +6 more
europepmc   +1 more source

MAVACAMTEN-LIKE CARDIAC MYOSIN INHIBITOR MYK-581 REDUCES RISK OF ATRIAL FIBRILLATION INDUCTION IN MURINE MODEL OF HYPERTROPHIC CARDIOMYOPATHY

Jeffrey Schmeckpeper, Kyungsoo Kim, Christopher Willits, Amanda Berge, Pallav Bulsara, Björn C. Knollmann   +5 more
openalex   +1 more source

Percutaneous Management of Right Ventricular Outflow Tract Obstruction in an Adult Patient After Atrial Switch: A Case for Targeted Infundibular Ablation

Catheterization and Cardiovascular Interventions, Volume 107, Issue 1, Page 357-360, January 1, 2026.
ABSTRACT Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis ...
Vera Osberghaus, Kerstin Wustmann, Pinar Bambul Heck, Stanimir Georgiev, Andreas Eicken, Peter Ewert, Katarzyna Gendera   +6 more
wiley   +1 more source

ODYSSEY-HCM trial (mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy). [PDF]

Eur Heart J Cardiovasc Pharmacother
Monda E, Limongelli G.
europepmc   +1 more source

INFECTIVE ENDOCARDITIS DUE TO GEMELLA-MORBILLORUM COMPLICATING HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [PDF]

, 1994
Campbell, NP, Kerr, JR, McGimpsey, JG, Webb, CH   +3 more
core   +1 more source

Engineered heart tissues facilitate functional characterization of noncoding variants implicated in Hypertrophic and Dilated Cardiomyopathy [PDF]

Zachary Weber, Tanner O. Monroe, Cory Holgren, Robert M. Mitchell, Li Zhang, Alexis G. Thornburg, Isabella M. Salamone, Megan J. Puckelwartz, Xuanyao Liu, Elizabeth M. McNally, Marcelo A. Nóbrega   +10 more
openalex   +1 more source

Excess Anterior Mitral Leaflet in a Patient With Hypertrophic Obstructive Cardiomyopathy and Systolic Anterior Motion [PDF]

, 2015
Satoshi Numata, Hitoshi Yaku, Kiyoshi Doi, Sachiko Yamazaki, Tsuneyasu Yamamoto, Takuma Kobayashi, Kaichiro Manabe, Kohei Kawazoe   +7 more
openalex   +1 more source